Bruker Corp (FRA:BKD)
€ 60.84 -3.22 (-5.03%) Market Cap: 8.80 Bil Enterprise Value: 9.83 Bil PE Ratio: 23.84 PB Ratio: 6.73 GF Score: 95/100

Bruker Corp at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 02:45PM GMT
Release Date Price: €33.57 (-1.47%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Great, and thank you everybody. Good morning. Our final presentation for Life Science Tools and Diagnostics. I am Jack Meehan, the analyst at Barclays, pleased to be joined by Bruker's CEO, Frank Laukien. We're going to start with 3 audience response questions. I will ask the question one. What do you view as Bruker's organic growth profile over the next 3 years? You have to wait to give us the answer.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

I'm sorry, I'm doing this now or...

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

You will give us the answer later in the presentation.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

I see, I see, okay.

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Most, right down the middle,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot